Aurus Capital is a Chilean investment firm established in 2008, headquartered in Santiago. It specializes in early-stage investments across various sectors, including life sciences, financial services, healthcare, industrial, technology, and logistics, focusing primarily on Latin America. Aurus is recognized as a pioneer in the region's venture capital industry, committed to fostering the local ecosystem by investing in exceptional talent and scalable technologies. The firm leverages its position as local investors to identify significant transformation opportunities within the market. Aurus enhances the value of its portfolio companies through a combination of experience, insights, and a robust network, supported by advisory committees that contribute to investment evaluations and mentorship initiatives for the firms in which it invests.
Copptech is a biotechnology company based in Santiago, Chile, that specializes in the development of antimicrobial technological solutions. The company harnesses the natural antimicrobial properties of copper, integrating them into various materials at a molecular level. This innovative technology is applicable to a wide range of products, including textile yarns, non-woven fabrics, and various polymers such as polyester, nylon, and polyethylene. Copptech's solutions are designed to eliminate and inhibit the growth of bacteria, viruses, and fungi, providing a protective barrier against pathogenic microorganisms on surfaces. By offering these patented antimicrobial ingredients, the company aims to enhance the safety and hygiene of textiles, building materials, and other products, thus addressing health concerns in everyday environments.
Algenis
Venture Round in 2016
Algenis is a biotechnology company based in Santiago de Chile, specializing in the research and development of natural sodium channel blocker molecules derived from microalgae. The company aims to become a leader in the production, formulation, and clinical development of bioactive molecules for medical applications, particularly as muscle relaxants and analgesics, as well as for treating neurological diseases. Algenis is focused on commercializing its products through licensing, co-development, or direct sales. Its initial therapeutic indication targets the treatment and healing of anal fissures, leveraging the unique properties of paralytic shellfish poison molecules for niche pharmaceutical markets.
Algenis
Venture Round in 2015
Algenis is a biotechnology company based in Santiago de Chile, specializing in the research and development of natural sodium channel blocker molecules derived from microalgae. The company aims to become a leader in the production, formulation, and clinical development of bioactive molecules for medical applications, particularly as muscle relaxants and analgesics, as well as for treating neurological diseases. Algenis is focused on commercializing its products through licensing, co-development, or direct sales. Its initial therapeutic indication targets the treatment and healing of anal fissures, leveraging the unique properties of paralytic shellfish poison molecules for niche pharmaceutical markets.
Andes Biotechnologies
Venture Round in 2014
Andes Biotechnologies S.A. is a biotechnology company based in Santiago, Chile, focused on the research, development, and marketing of innovative anti-cancer therapies in the United States and Europe. Founded in 2010, the company specializes in nucleic acid-based drug discovery, particularly targeting solid tumor cancers. It has developed proprietary technology utilizing long non-coding RNAs, specifically sense (S-RNA) and antisense (AS-RNA), which are synthesized in mitochondria and migrate to the nucleus. These oligonucleotide drugs selectively induce apoptosis in cancer cells, leaving normal cells unharmed. Andes Biotechnologies is currently advancing its lead drug, Andes-1537, through clinical development and holds an active investigational new drug (IND) application in the United States. The company is supported by an experienced management team and a strong network of collaborators in the cancer research field, along with a comprehensive intellectual property portfolio.
Levita Magnetics
Venture Round in 2014
Levita Magnetics SpA, established in January 2012 by Alberto Rodriguez-Navarro, is a Chilean medical device start-up focused on advancing surgical procedures through innovative technology. The company has developed a unique magnetic surgical platform called Magnetic Surgery®, which facilitates single and reduced port procedures, thereby promoting less invasive surgical techniques. This system utilizes a traumatic, shaftless design that eliminates the need for traditional trocars and shafted instruments, resulting in a clearer operative field and minimizing surgical trauma. By enhancing patient outcomes across various indications, Levita Magnetics aims to transform the landscape of surgery for broader patient populations, emphasizing both reduced invasiveness and improved cosmetic results.
ClickMagic
Venture Round in 2014
ClickMagic SpA is an affiliate and performance marketing company established in 2009, headquartered in Las Condes, Chile, with a presence in major Latin American markets including Brazil, Argentina, Mexico, Colombia, and Peru. The company specializes in providing online marketing services tailored for advertising agencies, advertisers, and publishers. Its offerings encompass affiliate and display marketing, lead generation, search engine and mobile marketing, as well as Facebook social ads. ClickMagic caters to a diverse array of industries, such as e-commerce, financial services, automotive, travel and tourism, entertainment, consumer goods, and education. By delivering high-quality, high-converting traffic for performance campaigns, ClickMagic assists advertisers in reaching their target audiences while enabling publishers to effectively monetize their inventory.
Andes Biotechnologies
Venture Round in 2014
Andes Biotechnologies S.A. is a biotechnology company based in Santiago, Chile, focused on the research, development, and marketing of innovative anti-cancer therapies in the United States and Europe. Founded in 2010, the company specializes in nucleic acid-based drug discovery, particularly targeting solid tumor cancers. It has developed proprietary technology utilizing long non-coding RNAs, specifically sense (S-RNA) and antisense (AS-RNA), which are synthesized in mitochondria and migrate to the nucleus. These oligonucleotide drugs selectively induce apoptosis in cancer cells, leaving normal cells unharmed. Andes Biotechnologies is currently advancing its lead drug, Andes-1537, through clinical development and holds an active investigational new drug (IND) application in the United States. The company is supported by an experienced management team and a strong network of collaborators in the cancer research field, along with a comprehensive intellectual property portfolio.
Algenis
Venture Round in 2013
Algenis is a biotechnology company based in Santiago de Chile, specializing in the research and development of natural sodium channel blocker molecules derived from microalgae. The company aims to become a leader in the production, formulation, and clinical development of bioactive molecules for medical applications, particularly as muscle relaxants and analgesics, as well as for treating neurological diseases. Algenis is focused on commercializing its products through licensing, co-development, or direct sales. Its initial therapeutic indication targets the treatment and healing of anal fissures, leveraging the unique properties of paralytic shellfish poison molecules for niche pharmaceutical markets.
Happyshop
Venture Round in 2013
We are convinced that mobile can push a change in consumer behavior never seen before, bridging online and offline into a single delightful experience. Mobile rapidly changes both consumers’ expectations and the overall shopping experience, that´s why Happyshop born…. Happyshop is a Software as a Service (SaaS) company for Mobile Marketing, specially designed for retail and his brands. We turns retail stores into interactive spaces where brands can comunicate in a personal way with the shopper enhancing their shopping experience and allowing brands to get the highest media performance. This company born´s to adapt to changes created by Mobile regarding consumers´expectation, our mision is to enhance the shopping experience and improve communication, preparing retail and brands for the new shopper 2.0 and the Onmichannel world. We drive happyshopppers! Because we only give them valued real-time content and offers in the best moment and place! For CPG brands Happyshop has created a new and innovative mobile advertising format named “adinstore™", brands can finally communicate in a relevant way with the consumer during their “purchase decision process”, creating brand experiences that capture and engage customers and prospects from our advertisers. The main benefits of adinstore is that we don't break the mobile user experience resulting in greater engagement (CTR > 10%) and performance. Happyshop, prize winner of Innova Chile, has earned a government sponsored grant, allowing the start-up to attract in his initial stage the interest of various investors and received more than 6,5 US$ MM (series A & B funding) Happyshop worked with a lot of merchants and leading retail companies in Latam (Falabella, Sodimac, Salcobrand, Parque Arauco) and important CPG brands (Loreal, Nivea, Nestle Eucerine, 3M..) and have operations in Chile and Colombia with his recently partnership with the biggest media company names "El Tiempo Casa Editorial (http://es.wikipedia.org/wiki/Casa_Editorial_El_Tiempo) http://www.crunchbase.com/organization/happyshop http://www.youtube.com/watch?v=0a0qyWb7dpI http://www.happyshop.com
Levita Magnetics
Venture Round in 2013
Levita Magnetics SpA, established in January 2012 by Alberto Rodriguez-Navarro, is a Chilean medical device start-up focused on advancing surgical procedures through innovative technology. The company has developed a unique magnetic surgical platform called Magnetic Surgery®, which facilitates single and reduced port procedures, thereby promoting less invasive surgical techniques. This system utilizes a traumatic, shaftless design that eliminates the need for traditional trocars and shafted instruments, resulting in a clearer operative field and minimizing surgical trauma. By enhancing patient outcomes across various indications, Levita Magnetics aims to transform the landscape of surgery for broader patient populations, emphasizing both reduced invasiveness and improved cosmetic results.
ClickMagic
Venture Round in 2013
ClickMagic SpA is an affiliate and performance marketing company established in 2009, headquartered in Las Condes, Chile, with a presence in major Latin American markets including Brazil, Argentina, Mexico, Colombia, and Peru. The company specializes in providing online marketing services tailored for advertising agencies, advertisers, and publishers. Its offerings encompass affiliate and display marketing, lead generation, search engine and mobile marketing, as well as Facebook social ads. ClickMagic caters to a diverse array of industries, such as e-commerce, financial services, automotive, travel and tourism, entertainment, consumer goods, and education. By delivering high-quality, high-converting traffic for performance campaigns, ClickMagic assists advertisers in reaching their target audiences while enabling publishers to effectively monetize their inventory.
Algenis
Venture Round in 2012
Algenis is a biotechnology company based in Santiago de Chile, specializing in the research and development of natural sodium channel blocker molecules derived from microalgae. The company aims to become a leader in the production, formulation, and clinical development of bioactive molecules for medical applications, particularly as muscle relaxants and analgesics, as well as for treating neurological diseases. Algenis is focused on commercializing its products through licensing, co-development, or direct sales. Its initial therapeutic indication targets the treatment and healing of anal fissures, leveraging the unique properties of paralytic shellfish poison molecules for niche pharmaceutical markets.
Modyo
Venture Round in 2012
Modyo, founded in 2007 in Santiago, Chile, is a developer of a digital experience platform designed to address complex challenges in channel building for organizations. The company focuses on creating cloud-based digital products that seamlessly integrate with core business systems, enhancing the interaction between organizations and their customers. Modyo's platform enables financial institutions and large enterprises to deliver omnichannel experiences, allowing them to better understand, analyze, and engage with their digital clientele. With a diverse team of professionals from various countries, Modyo emphasizes collaboration and innovation, leveraging the high caliber of engineering talent in Chile to drive its mission of digital transformation for major companies worldwide.
Andes Biotechnologies
Venture Round in 2012
Andes Biotechnologies S.A. is a biotechnology company based in Santiago, Chile, focused on the research, development, and marketing of innovative anti-cancer therapies in the United States and Europe. Founded in 2010, the company specializes in nucleic acid-based drug discovery, particularly targeting solid tumor cancers. It has developed proprietary technology utilizing long non-coding RNAs, specifically sense (S-RNA) and antisense (AS-RNA), which are synthesized in mitochondria and migrate to the nucleus. These oligonucleotide drugs selectively induce apoptosis in cancer cells, leaving normal cells unharmed. Andes Biotechnologies is currently advancing its lead drug, Andes-1537, through clinical development and holds an active investigational new drug (IND) application in the United States. The company is supported by an experienced management team and a strong network of collaborators in the cancer research field, along with a comprehensive intellectual property portfolio.
Taggify
Series A in 2012
Taggify Inc. is a company based in Buenos Aires, Argentina, specializing in digital out-of-home advertising. It provides a platform that enables brands to target outdoor audiences with relevant advertisements in real-time. Taggify's technology includes a full-stack programmatic digital out-of-home (DOOH) solution that enhances user experience and allows brands to forecast campaign performance before launch. In addition to outdoor advertising, Taggify offers services for publishers and bloggers to monetize their websites through contextual advertisements in images, text, videos, and links. Since securing initial investment in 2012, Taggify has established itself as a profitable entity within the growing $16 billion digital out-of-home advertising market.
Happyshop
Series B in 2012
We are convinced that mobile can push a change in consumer behavior never seen before, bridging online and offline into a single delightful experience. Mobile rapidly changes both consumers’ expectations and the overall shopping experience, that´s why Happyshop born…. Happyshop is a Software as a Service (SaaS) company for Mobile Marketing, specially designed for retail and his brands. We turns retail stores into interactive spaces where brands can comunicate in a personal way with the shopper enhancing their shopping experience and allowing brands to get the highest media performance. This company born´s to adapt to changes created by Mobile regarding consumers´expectation, our mision is to enhance the shopping experience and improve communication, preparing retail and brands for the new shopper 2.0 and the Onmichannel world. We drive happyshopppers! Because we only give them valued real-time content and offers in the best moment and place! For CPG brands Happyshop has created a new and innovative mobile advertising format named “adinstore™", brands can finally communicate in a relevant way with the consumer during their “purchase decision process”, creating brand experiences that capture and engage customers and prospects from our advertisers. The main benefits of adinstore is that we don't break the mobile user experience resulting in greater engagement (CTR > 10%) and performance. Happyshop, prize winner of Innova Chile, has earned a government sponsored grant, allowing the start-up to attract in his initial stage the interest of various investors and received more than 6,5 US$ MM (series A & B funding) Happyshop worked with a lot of merchants and leading retail companies in Latam (Falabella, Sodimac, Salcobrand, Parque Arauco) and important CPG brands (Loreal, Nivea, Nestle Eucerine, 3M..) and have operations in Chile and Colombia with his recently partnership with the biggest media company names "El Tiempo Casa Editorial (http://es.wikipedia.org/wiki/Casa_Editorial_El_Tiempo) http://www.crunchbase.com/organization/happyshop http://www.youtube.com/watch?v=0a0qyWb7dpI http://www.happyshop.com
Levita Magnetics
Venture Round in 2012
Levita Magnetics SpA, established in January 2012 by Alberto Rodriguez-Navarro, is a Chilean medical device start-up focused on advancing surgical procedures through innovative technology. The company has developed a unique magnetic surgical platform called Magnetic Surgery®, which facilitates single and reduced port procedures, thereby promoting less invasive surgical techniques. This system utilizes a traumatic, shaftless design that eliminates the need for traditional trocars and shafted instruments, resulting in a clearer operative field and minimizing surgical trauma. By enhancing patient outcomes across various indications, Levita Magnetics aims to transform the landscape of surgery for broader patient populations, emphasizing both reduced invasiveness and improved cosmetic results.
ClickMagic
Venture Round in 2011
ClickMagic SpA is an affiliate and performance marketing company established in 2009, headquartered in Las Condes, Chile, with a presence in major Latin American markets including Brazil, Argentina, Mexico, Colombia, and Peru. The company specializes in providing online marketing services tailored for advertising agencies, advertisers, and publishers. Its offerings encompass affiliate and display marketing, lead generation, search engine and mobile marketing, as well as Facebook social ads. ClickMagic caters to a diverse array of industries, such as e-commerce, financial services, automotive, travel and tourism, entertainment, consumer goods, and education. By delivering high-quality, high-converting traffic for performance campaigns, ClickMagic assists advertisers in reaching their target audiences while enabling publishers to effectively monetize their inventory.
Hadza
Venture Round in 2011
Hadza operates an online platform that shares videos, photos, and audios. The company develops a technology to synchronize videos taken at any event by multiple smartphones. Hadza is based in Chile, Minas Gerais, Brazil.
Happyshop
Series A in 2011
We are convinced that mobile can push a change in consumer behavior never seen before, bridging online and offline into a single delightful experience. Mobile rapidly changes both consumers’ expectations and the overall shopping experience, that´s why Happyshop born…. Happyshop is a Software as a Service (SaaS) company for Mobile Marketing, specially designed for retail and his brands. We turns retail stores into interactive spaces where brands can comunicate in a personal way with the shopper enhancing their shopping experience and allowing brands to get the highest media performance. This company born´s to adapt to changes created by Mobile regarding consumers´expectation, our mision is to enhance the shopping experience and improve communication, preparing retail and brands for the new shopper 2.0 and the Onmichannel world. We drive happyshopppers! Because we only give them valued real-time content and offers in the best moment and place! For CPG brands Happyshop has created a new and innovative mobile advertising format named “adinstore™", brands can finally communicate in a relevant way with the consumer during their “purchase decision process”, creating brand experiences that capture and engage customers and prospects from our advertisers. The main benefits of adinstore is that we don't break the mobile user experience resulting in greater engagement (CTR > 10%) and performance. Happyshop, prize winner of Innova Chile, has earned a government sponsored grant, allowing the start-up to attract in his initial stage the interest of various investors and received more than 6,5 US$ MM (series A & B funding) Happyshop worked with a lot of merchants and leading retail companies in Latam (Falabella, Sodimac, Salcobrand, Parque Arauco) and important CPG brands (Loreal, Nivea, Nestle Eucerine, 3M..) and have operations in Chile and Colombia with his recently partnership with the biggest media company names "El Tiempo Casa Editorial (http://es.wikipedia.org/wiki/Casa_Editorial_El_Tiempo) http://www.crunchbase.com/organization/happyshop http://www.youtube.com/watch?v=0a0qyWb7dpI http://www.happyshop.com
Modyo
Venture Round in 2011
Modyo, founded in 2007 in Santiago, Chile, is a developer of a digital experience platform designed to address complex challenges in channel building for organizations. The company focuses on creating cloud-based digital products that seamlessly integrate with core business systems, enhancing the interaction between organizations and their customers. Modyo's platform enables financial institutions and large enterprises to deliver omnichannel experiences, allowing them to better understand, analyze, and engage with their digital clientele. With a diverse team of professionals from various countries, Modyo emphasizes collaboration and innovation, leveraging the high caliber of engineering talent in Chile to drive its mission of digital transformation for major companies worldwide.
Andes Biotechnologies
Venture Round in 2011
Andes Biotechnologies S.A. is a biotechnology company based in Santiago, Chile, focused on the research, development, and marketing of innovative anti-cancer therapies in the United States and Europe. Founded in 2010, the company specializes in nucleic acid-based drug discovery, particularly targeting solid tumor cancers. It has developed proprietary technology utilizing long non-coding RNAs, specifically sense (S-RNA) and antisense (AS-RNA), which are synthesized in mitochondria and migrate to the nucleus. These oligonucleotide drugs selectively induce apoptosis in cancer cells, leaving normal cells unharmed. Andes Biotechnologies is currently advancing its lead drug, Andes-1537, through clinical development and holds an active investigational new drug (IND) application in the United States. The company is supported by an experienced management team and a strong network of collaborators in the cancer research field, along with a comprehensive intellectual property portfolio.
ClickMagic
Series A in 2010
ClickMagic SpA is an affiliate and performance marketing company established in 2009, headquartered in Las Condes, Chile, with a presence in major Latin American markets including Brazil, Argentina, Mexico, Colombia, and Peru. The company specializes in providing online marketing services tailored for advertising agencies, advertisers, and publishers. Its offerings encompass affiliate and display marketing, lead generation, search engine and mobile marketing, as well as Facebook social ads. ClickMagic caters to a diverse array of industries, such as e-commerce, financial services, automotive, travel and tourism, entertainment, consumer goods, and education. By delivering high-quality, high-converting traffic for performance campaigns, ClickMagic assists advertisers in reaching their target audiences while enabling publishers to effectively monetize their inventory.
Andes Biotechnologies
Series A in 2010
Andes Biotechnologies S.A. is a biotechnology company based in Santiago, Chile, focused on the research, development, and marketing of innovative anti-cancer therapies in the United States and Europe. Founded in 2010, the company specializes in nucleic acid-based drug discovery, particularly targeting solid tumor cancers. It has developed proprietary technology utilizing long non-coding RNAs, specifically sense (S-RNA) and antisense (AS-RNA), which are synthesized in mitochondria and migrate to the nucleus. These oligonucleotide drugs selectively induce apoptosis in cancer cells, leaving normal cells unharmed. Andes Biotechnologies is currently advancing its lead drug, Andes-1537, through clinical development and holds an active investigational new drug (IND) application in the United States. The company is supported by an experienced management team and a strong network of collaborators in the cancer research field, along with a comprehensive intellectual property portfolio.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.